Citius Pharmaceuticals, Inc. (CTXR)
0.7652
-0.03
(-3.55%)
USD |
NASDAQ |
Feb 13, 16:00
0.75
-0.02
(-1.99%)
After-Hours: 20:00
Citius Pharmaceuticals Profit Margin (Quarterly) : -238.2% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Citius Oncology, Inc. | -140.3% |
| Dynavax Technologies Corp. | 28.38% |
| Applied Therapeutics, Inc. (DELISTED) | -1.90K% |
| Dermata Therapeutics, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 25.76% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -52.36% |
| Return on Assets | -30.29% |
| Return on Invested Capital | -51.43% |
| Gross Profit Margin (Quarterly) | 65.45% |
| Operating Margin (Quarterly) | -228.7% |
| Return on Net Operating Assets | -31.24% |